Literature DB >> 1664411

A gene encoding a fibroblast growth factor receptor isolated from the Huntington disease gene region of human chromosome 4.

L M Thompson1, S Plummer, M Schalling, M R Altherr, J F Gusella, D E Housman, J J Wasmuth.   

Abstract

The gene responsible for Huntington disease (HD), an autosomal dominant neurodegenerative disorder, is located near the terminus of the short arm of chromosome 4. Detailed genetic linkage and physical mapping studies have defined a region of approximately 2.5 million basepairs where the disease gene is likely to be located. Efforts to identify the disease gene are now focused on the identification and characterization of expressed genes in this region. Nucleotide sequence analysis of a cDNA clone derived from the HD gene region has revealed that it encodes a member of the fibroblast growth factor subfamily of tyrosine kinase receptors, some members of which are known to be involved in the differentiation and survival of certain cell types within the central nervous system. Histochemical analysis using in situ hybridization revealed its expression in many areas of the brain, among them being the caudate and putamen. The nature of this gene, FGFR3, and its map location make it a possible candidate for the HD gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664411     DOI: 10.1016/0888-7543(91)90041-c

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  The distribution of somatic H1 subtypes is non-random on active vs. inactive chromatin: distribution in human fetal fibroblasts.

Authors:  M H Parseghian; R L Newcomb; S T Winokur; B A Hamkalo
Journal:  Chromosome Res       Date:  2000       Impact factor: 5.239

2.  Bioinformatics analysis of the target gene of fibroblast growth factor receptor 3 in bladder cancer and associated molecular mechanisms.

Authors:  Xing Ai; Zhuo-Min Jia; Juan Wang; Gui-Ping DI; X U Zhang; Fengling Sun; Tong Zang; Xiumei Liao
Journal:  Oncol Lett       Date:  2015-05-19       Impact factor: 2.967

3.  New overgrowth syndrome and FGFR3 dosage effect.

Authors:  M M Cohen; G Neri
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

Review 4.  Advances in research on and diagnosis and treatment of achondroplasia in China.

Authors:  Yao Wang; Zeying Liu; Zhenxing Liu; Heng Zhao; Xiaoyan Zhou; Yazhou Cui; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2013-05

5.  Chimeras of the native form or achondroplasia mutant (G375C) of human fibroblast growth factor receptor 3 induce ligand-dependent differentiation of PC12 cells.

Authors:  L M Thompson; S Raffioni; J J Wasmuth; R A Bradshaw
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

6.  The fibroblast growth factor receptor-1 is necessary for the induction of neurite outgrowth in PC12 cells by aFGF.

Authors:  H Y Lin; J Xu; D M Ornitz; S Halegoua; M J Hayman
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

7.  Central nervous system phenotypes in craniosynostosis.

Authors:  Kristina Aldridge; Jeffrey L Marsh; Daniel Govier; Joan T Richtsmeier
Journal:  J Anat       Date:  2002-07       Impact factor: 2.610

8.  A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia.

Authors:  A Superti-Furga; G Eich; H U Bucher; J Wisser; A Giedion; R Gitzelmann; B Steinmann
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

9.  Molecular definition of the smallest region of deletion overlap in the Wolf-Hirschhorn syndrome.

Authors:  K Y Gandelman; L Gibson; M S Meyn; T L Yang-Feng
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

10.  Genetic analysis of sporadic and familial interstitial pneumonia.

Authors:  David A Schwartz
Journal:  Proc Am Thorac Soc       Date:  2008-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.